Skip to content
RushPR News – Lifestyle
Author:
BioStem Technologies, Inc.
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
October 1, 2026
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 30, 2026
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
September 18, 2026
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
September 4, 2026
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
BioStem Technologies to Present at the Sidoti MicroCap Conference
August 14, 2026
BioStem Technologies Reports Second Quarter 2026 Financial Results
August 12, 2026
BioStem Technologies Announces Nasdaq Uplisting
August 6, 2026
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
July 29, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
July 10, 2026
1
2
Next Page
→